March 16, 2015
Takeda Pharmaceutical’s acid-related disorder treatment Takecab (vonoprazan fumarate) surged to number one in January’s “mind share” ranking as a drug that left the strongest impression on physicians, according to the marketing research firm Anterio Inc. Takecab captured the top ranking...read more